Frontlight ResearchEarly access
Trial site
Japanese Red Cross Nagasaki Genbaku Hospital
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration3 trials
- Diffuse large B-cell lymphoma2 trials
- Acute myeloid leukaemia1 trial
- Diabetic eye disease1 trial
- Follicular lymphoma1 trial
- Hodgkin lymphoma1 trial
- Mantle cell lymphoma1 trial
- Multiple myeloma1 trial
- Myelodysplastic syndromes1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 33 trials
- Phase 1/22 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Active, not recruiting4 trials
- Completed2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche2 trials
- Bayer1 trial
- Celgene1 trial
- Kyowa Kirin Co., Ltd.1 trial
- Ono Pharmaceutical Co., Ltd.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
A Study of TAK-226 for Anemia in Japanese Patients With Lower-Risk Myelodysplastic Syndromes
Recruiting
Active, not recruiting
A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL
Active, not recruiting
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026